Sandra Jordaan

Title: Innovations of Sandra Jordaan in Apoptosis Detection

Introduction

Sandra Jordaan is a notable inventor based in Cape Town, South Africa. She has made significant contributions to the field of biotechnology, particularly in the detection of apoptosis, which is a crucial process in cellular biology.

Latest Patents

Sandra holds a patent for "Fusion proteins for the detection of apoptosis." This invention relates to fusion proteins capable of binding to phosphatidylserine, which includes a phosphatidylserine binding ligand and a modified O6-alkylguanine-DNA alkyltransferase. These proteins can autoconjugate to an O6-benzylguanine-modified label, allowing them to bind to phosphatidylserine on the surface of cells undergoing apoptosis. The patent also covers recombinant polypeptide precursors of the fusion proteins, which consist of a secretion leader sequence, purification tag, protease cleavage site, and the fusion protein itself. Additionally, the invention includes nucleic acids encoding the recombinant polypeptide precursor, vectors comprising the nucleic acids, host cells containing the vectors, methods for producing the fusion proteins, and kits and assays for detecting apoptosis. Sandra has 1 patent to her name.

Career Highlights

Sandra is affiliated with the University of Cape Town, where she conducts her research and development work. Her innovative approach to apoptosis detection has the potential to advance medical diagnostics and therapeutic strategies.

Collaborations

Some of her notable coworkers include Eden Padayachee and Fleury Augustin Nsole Biteghe, who contribute to her research endeavors.

Conclusion

Sandra Jordaan's work in the field of apoptosis detection exemplifies the impact of innovative research in biotechnology. Her contributions are paving the way for advancements in medical science and diagnostics.